Medroxyprogesterone acetate Injection 150 mg/ mL

πŸ”Ή Medroxyprogesterone Acetate Injection 150 mg/mL – As Licensed


πŸ“„ Description:

Medroxyprogesterone Acetate (MPA) 150 mg/mL injection is a long-acting progestin-only injectable contraceptive. It is also used for endometriosis, menstrual disorders, and sometimes in hormone-sensitive cancers. It provides sustained release of the hormone when administered intramuscularly.


πŸ’Š Prescription / Use:

Indications:

  • Long-term contraception (up to 3 months per injection)
  • Dysfunctional uterine bleeding
  • Endometriosis
  • Secondary amenorrhea
  • Palliative treatment of endometrial or renal carcinoma

Dosage (for contraception):

  • 150 mg every 3 months (12–13 weeks) by deep intramuscular injection, usually in the gluteal or deltoid muscle.

Route: Intramuscular (IM) injection


πŸ”¬ Nature:

  • Type: Synthetic progestin hormone
  • Class: Hormonal contraceptive / Hormone therapy
  • Form: Sterile injectable suspension
  • Mechanism of Action:
    • Inhibits ovulation
    • Thickens cervical mucus
    • Thins the endometrial lining

🌟 Advantages:

  • Highly effective and long-acting (3 months)
  • No daily pills needed
  • Suitable for breastfeeding women
  • Decreases menstrual cramps and blood loss
  • May reduce risk of endometrial cancer and iron-deficiency anemia
  • Privacy: No visible signs of contraceptive use

πŸ“¦ Packaging:

  • Available in 1 mL vials or prefilled syringes (150 mg/mL)
  • Single-dose packaging
  • Clearly labeled with strength, batch number, and expiry date

🧊 Storage:

  • Store at 15Β°C to 30Β°C (room temperature)
  • Do not freeze
  • Shake well before use (suspension form)
  • Protect from direct light

⚠️ Precautions:

Contraindications:

  • Known or suspected pregnancy
  • History of thrombosis or thromboembolic disorders
  • Liver dysfunction or liver tumors
  • Known or suspected breast/genital malignancy
  • Undiagnosed vaginal bleeding

Use with caution in:

  • Adolescents (due to potential effect on bone density)
  • Patients with a history of depression
  • Diabetics (may alter glucose tolerance)

Common Side Effects:

  • Irregular bleeding or amenorrhea
  • Weight gain
  • Headache, dizziness, or fatigue
  • Bone density reduction with long-term use
  • Delayed return to fertility (4–10 months post last injection)

πŸ‘©β€βš•οΈ Patient Advice:

  • Administered every 3 months by a healthcare provider
  • Not suitable if immediate return to fertility is desired
  • Calcium and Vitamin D intake recommended for bone health
  • Expect menstrual changes (light bleeding or no periods)
  • Inform doctor if you experience:
    • Severe headaches
    • Vision problems
    • Persistent abdominal pain
    • Mood changes
  • Do not use if pregnantβ€”pregnancy test may be needed before first dose
  • Carry a medical alert card stating you’re using injectable contraception

Leave a Comment

Your email address will not be published. Required fields are marked *

Call Now Button